Goodnow, Robert A. Jr
Dumelin, Christoph E.
Keefe, Anthony D.
Article History
First Online: 9 December 2016
Change Date: 30 January 2017
Change Type: Correction
Change Details: The details of reference 119 were incorrect and there were also some minor typographical errors. These errors have been corrected in the online version of the article.
Competing interests
: At the time of writing this manuscript R.A.G. was an Executive Director at AstraZeneca. C.E.D. is an investigator at Novartis Pharma, and A.D.K. is a Director at X-Chem.